WHO public consultation on draft Target Product Profiles for Tuberculosis Preventive Treatment

Tuberculosis (TB) is a major yet preventable global health problem, with an estimated 10 million new cases worldwide in 2018, resulting in more than 1.5 million deaths, making it the leading infectious disease cause of death worldwide. An estimated one fourth of the world’s population is infected with the TB bacterium, of whom 5–10% advance…

making-available-free-paediatric-medicine-can-accelerate-elimination-of-congenital-chagas-disease

Making available free paediatric medicine can accelerate elimination of congenital Chagas disease

The donation of an essential antiparasitic medicine can potentially accelerate the elimination of Chagas disease infection in children. A pediatric presentation of benznidazole with accurate dosage and will soon be made available freely to address a long-standing gap in the treatment of congenital infections of Chagas disease.   The donation, by the Mundo Sano Foundation1 and…

Chagas disease: providing free paediatric medicine can enhance diagnosis and treatment

Documentation resulting in the donation of an important antiparasitic medicine for the treatment of Chagas illness to the World Health Organization (WHO) is within the ultimate stage of preparation. A 3-year settlement, between the Mundo Sano Foundation1 (Brazil) and WHO, is anticipated to make obtainable 108 000 tablets of the paediatric formulation of benznidazole2 –…